CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder
- 20 June 2006
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1095 (1) , 154-158
- https://doi.org/10.1016/j.brainres.2006.04.026
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neurobiology of suicidal behaviourNature Reviews Neuroscience, 2003
- Attempted Suicide Characteristics and Cerebrospinal Fluid Amine Metabolites in Depressed InpatientsNeuropsychopharmacology, 1996
- Neuropeptide Y in Frontal Cortex Is Not Altered in Major DepressionJournal of Neurochemistry, 1995
- Neuropeptides in Relation to Suicidal Behavior in DepressionNeuropsychobiology, 1993
- Reduced Neuropeptide Y Concentrations in Suicide BrainJournal of Neurochemistry, 1992
- HPA-related CSF neuropeptides in suicide attemptersEuropean Neuropsychopharmacology, 1992
- Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnessesActa Psychiatrica Scandinavica, 1990
- CSF monoamine metabolites of depressed patients during illness and after recoveryActa Psychiatrica Scandinavica, 1984
- "Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?Science, 1976
- Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sexNeuropharmacology, 1971